BIOAEROSOLS: Role in Healthcare Institutions
Abstract
Bioaerosols are airborne particles that are living or originate from living organisms (bacteria, viruses and fungi). In recent years a number of factors have stimulated an increased awareness of the presence of potentially pathogenic bioaerosols in hospital environments and the detrimental health effects associated with them. The incidence of hospital acquired infection is a serious and widespread problem, with an estimated 1 in 10 patients acquiring an infection during a hospital stay. There are a whole range of potentially pathogenic microorganisms associated with nosocomial infections many of which are opportunistic pathogens which frequently cause respiratory infections particularly in immunocompromised patients. The practical importance and frequency of airborne nosocomial infections has been a matter of dispute for many years. This is because most of the pathogens acquired in hospitals are able to use various different routes of infecting the patient’s body so that it may be difficult or even impossible to prove an individual infection to be airborne. The assessment of indirect airborne infections caused by infective particles derived from dust introduced to the hospital environment is much more difficult. Many Gram-positive bacteria such as Staphylococcus aureus, mycobacteria, nocardiae, and endospores of clostridia and bacilli, as well as the reproductive elements of fungi do remain viable and infective in dry dust and may therefore infect patients when the dust is disturbed. In contrast to nosocomial infections due to Gram-negative bacteria, against which most preventive measures have been concentrated in the past and which are usually not airborne in origin, it appears that the possibility of direct or indirect transmission of hospital pathogens through bioaerosols has been underestimated. In the context of healthcare settings, bioaerosols can cause occupational hazards and nosocomial infections. Modern built environment can be a potential source of bioaerosols. Bioaerosol monitoring in hospitals can be used for tracking of nosocomial infections, identify the source and spread
of airborne microorganisms to control hospital associated infections (HAI). This will also serve as a tool to measure biosafety while handling biohazardous materials. The complexity of these bio-aerosols requires a multidisciplinary approach. Their presence in air is the result of dispersal from a site of colonisation or growth. The evaluation of bio-aerosols includes use of variety of methods for sampling depending on the concentration of microorganisms expected. There is heightened awareness regarding the study of bioaerosols and its impact on human health and quality of indoor air and environment. This article is a review on role of bioaerosols in hospital environment.
References
2. Stetzenbach LD, Buttner MP, Cruz P. Detection and enumeration of airborne biocontaminants. Curr Opin Biotechnol. 2004; 15:170-4.
3. Available at: http://www.airqualitydirect.com/bio-aerosols. htm. Accessed September 02, 2007.4. Schaal KP. Medical and microbiological problems arising
from airborne infection in hospitals. J Hosp Infect. 1991;18 (Suppl A):451-9. 5. Ayliffe GA. Role of the environment of the operating suite in surgical wound infection Rev Infect Dis. 1991;13(Suppl.10):S800-S804.
6. Cox CS, Wathes CM. Bio-aerosols in the environment. In: Bio-aerosols Handbook. Cox CS, Wathes CM, Eds. (Lewis Publishers, Boca Raton, FL) 1995:11-14.
7. Brachman, PS . Nosocomial infection – airborne or not? Proceedings of the International Conference on Nosocomial Infections. American Hospital Association. 1970; 189-192.
8. Stetzenbach LD. Introduction to Aerobiology, Chapter 72. In: Manual of Environmental Microbiology, 2 nd ed. Hurst CJ, Crawford RL, Knudsen G, McInerney M, Stetzenbach LD, Eds. (ASM Press, Washington DC) 2002:801-813.
9. Roy CJ, Milton DK. Airborne Transmission of Communicable Infection - The Elusive Pathway. N Engl J Med. 2004;350:1710-12.
10. Hauswirth DW, Sundy JS. Bio-aerosols and Innate Immune Responses in Airway Diseases. Curr Opin Allergy Clin Immunol. 2004; 4:361-366.
11. Lugauskas A. Filamentous Fungi Isolated in Hospitals and Some Medical Institutions in Lithuania. Indoor Built Environ. 2004; 13:101-108.
12. Yu ITS, Li Y, Wong TW, Tam W, Chan AT, Lee JHW, et al . Evidence of Airborne Transmission of the Severe Acute Respiratory Syndrome Virus. N Engl J Med. 2004; 350:1731- 1739.
13. Lawande RV, Abraham SN, John I and Egler LJ. Recovery of soil Amoebas from the nasal passages of children during the dusty harmattan period in Zaria. Am J Clin Pathol.
1979; 71:201-203.
14. Li CS, Hou PA. Bio-aerosol characteristics in hospital clean rooms. Sci Total Environ. 2003; 305:169-176.
15. Yi-Chyun Hsu, Pei-Yi Kung, Ting-Nien Wu, Yun-Hwei Shen. Characterization of Indoor-Air Bioaerosols in Southern Taiwan. Aerosol and Air Quality Research. 2012; 12: 651–661.
16. Rocha CA , Báez NA, Villarroel EV, Quintero GM. Study of Bioaerosols in Surgical Theaters and Intensive Care Units from a Public General Hospital. The Journal of Bioscience and Medicine. 2012; 2(3):1-10
17. Mandal M, Brandl M. Bioaerosols in Indoor Environment - a review with Special Reference to Residential and Occupational Locations. Open Environ B Monitoring J. 2011;4:83-96.
18. Kelkar U, Kelkar S, Bal AM, Kulkarni S, Kulkarni S. Microbiological Evaluation of Various Parameters in Ophthalmic Operating Rooms. The Need to Establish Guidelines. Indian J Ophthalmol. 2002; 51:171-76.
19. Ravisankar S, Srikanth P, Steinberg R, Balakrishnan K. ′Characterization of Bio-aerosols in a Health Care Facility in India′ In: ACGIH-AIHce 2005: International Occupational Safety and Health Issues held at Anaheim, California, poster session 402, abstract no. 277. 2005
20. Kowalski WJ. The epidemiology and aerobiological pathways of airborne nosocomial infections and methods of air and surface disinfection. HPAC Engineering: Air- Treatment Systems for Controlling Hospital-Acquired Infections 2007. Available at: http://www.hpac.com/Issue/ Article/44503/ AirTreatment_Systems_for_Controlling_ HospitalAcquired_Infections Accessed August 03, 2007.
21. Beggs, CB, Dean, S, Donnelly, JK, Kerr, KG., Mara, DD, Thornton, J, Todd, NJ, Sleigh, PA, and Qureshi, A. The use of small negative air ions to disinfect Acinetobacter spp. and other airborne pathogens in UK hospital buildings (pilot study). NHS Estates and Development Fund, September 2007
22. Nevalainen, A, Willeke, K, Liebhaber, F, Pastuszka, J, Burge, J and Henningson, E. Bioaerosol Sampling. Chapter 21 Aerosol measurement: principles, techniques and application.
(K. Willeke and P.A. Baron, editors), Van Nostrand Reinhold, New York, NY. 1993.
23. Eduard W, Heederik D. Methods for quantitative assessment of airborne levels of non-infectious microorganisms in highly contaminated work environments. Am Ind Hyg Assoc J. 1998; 59:113-27.
24. Macher J, Ammann HA, Burge HA, Milton DK, Morey PR. (Eds) Chapter 1. In: Bio-aerosols: Assessment and Control(American Conference of Governmental Industrial Hygienists, Cincinnati) 1999:1-5.
25. Available at: http://www.pollutionissues.com/Ho-Li/ Indoor-Air-Pollution.html. Accessed November 10, 2006.
26. Mandal J, Brandl. Bioaerosols in Indoor Environment - A Review with Special Reference to Residential and Occupational Locations. Open Environ B Monitoring J. 2011;4:83-96.
